Regulation & law · 28/04/2026

US Department of Justice Reschedules FDA-Approved Marijuana Products to Schedule III

The US Department of Justice has issued a final rule rescheduling FDA-approved products containing marijuana from Schedule I to Schedule III, in accordance with the Controlled Substances Act, to align with US obligations under the Single Convention on Narcotic Drugs, 1961, and to permit the import and export of these products under state medical marijuana licenses.